SEATTLE (AP) _ CTI BioPharma Corp. (CTIC) on Thursday reported a second-quarter loss of $11.3 million, after reporting a profit in the same period a year earlier.

The Seattle-based company said it had a loss of 20 cents per share.

The biotechnology company posted revenue of $613,000 in the period.

The company's shares closed at $2.25. A year ago, they were trading at $3.43.


This story was generated by Automated Insights ( using data from Zacks Investment Research. Access a Zacks stock report on CTIC at